Skip to content

The healing effect of Panthenol eye drops on eye wounds from laser vision correction surgeries

The effect of D-panthenol on corneal epithelial healing after surface laser ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN81441126
Enrollment
45
Registered
2018-10-17
Start date
2016-05-01
Completion date
Unknown
Last updated
2019-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epithelial corneal defects, created iatrogeniccally during surface laser ablation procedure Eye Diseases Epithelial corneal defects, created iatrogeniccally during surface laser ablation procedure

Interventions

Patients serve as their own control, with one eye randomly allocated to receive D-panthenol in propyl-methyl-cellulose eye drops four times daily for 2 months, and the other to receive carboxy methyl

Sponsors

The Eye Consultants Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Ametropia 2. Seeking laser vision correction 3. Best corrected visual acuity 20/20 or better in each eye 4. Eyes fit for laser ablation procedure and otherwise normal

Exclusion criteria

Exclusion criteria: 1. Previous ocular surgery 2. Concomitant ocular morbidity

Design outcomes

Primary

MeasureTime frame
Rate of epithelial healing, assessed by: 1. Rate of epithelial closure, assessed on a slit lamp bio-microscope on days 1, 2 and 3 2. Corneal haze, assessed on a slit lamp bio-microscope at weeks 1, 2, 3 and 4, and the end of month 2

Secondary

MeasureTime frame
1. Effect of D-panthenol on visual acuity, assessed by: 1.1. Uncorrected visual acuity (UCVA) using a Snellen's chart at days 1, 2 and 3, weeks 1, 2, 3 and 4, and the end of month 2 1.2. Residual subjective refraction, assessed using an auto-refractometer at weeks 1, 2, 3, and 4, and the end of month 2 2. Subjective comfort with or without D-panthenol, assessed by asking participants to rate comfort out of 5, with 0 indicating "no discomfort" and 5 being "severe intolerant symptoms", at weeks 1, 2, 3 and 4, and the end of month 2

Countries

Saudi Arabia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 23, 2026